Education
About Us
Working with TipRanks
Follow Us
Vivani Medical, Inc. (DE:U5P)
:U5P
U5P Stock Chart & Stats
€1.16
-€0.01(-0.88%)
At close: 4:00 PM EST
€1.16
-€0.01(-0.88%)
Day’s Range― - ―
52-Week Range€0.75 - €1.60
Previous CloseN/A
Volume0.00
Average Volume (3M)66.00
Market Cap
€82.46M
Enterprise Value€88.25M
Total Cash (Recent Filing)€6.79M
Total Debt (Recent Filing)€18.62M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Nov 18, 2025EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding59,243,904
10 Day Avg. Volume200
30 Day Avg. Volume66
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.62
Price to Sales (P/S)0.00
P/FCF Ratio-2.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.44Price Target Upside196.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentVivani is planning for both studies in parallel with the Phase 1 expected to initiate and the Phase 2 to initiate shortly after Phase 1 completion.
Market OpportunityThere is a significant market opportunity with a 3-6 month semaglutide implant for weight loss.
Product DifferentiationNPM-139 is the only 6-month implant which provides significant differentiation as it eliminates the need for weekly injectables or daily orals.
Bears Say
Vivani Medical News
U5P FAQ
What was Vivani Medical, Inc.’s price range in the past 12 months?
Vivani Medical, Inc. lowest stock price was €0.74 and its highest was €1.60 in the past 12 months.
What is Vivani Medical, Inc.’s market cap?
Vivani Medical, Inc.’s market cap is €82.46M.
When is Vivani Medical, Inc.’s upcoming earnings report date?
Vivani Medical, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 22 days.
How were Vivani Medical, Inc.’s earnings last quarter?
Vivani Medical, Inc. released its earnings results on Aug 13, 2025. The company reported -€0.103 earnings per share for the quarter, missing the consensus estimate of -€0.086 by -€0.017.
Is Vivani Medical, Inc. overvalued?
According to Wall Street analysts Vivani Medical, Inc.’s price is currently Undervalued.
Does Vivani Medical, Inc. pay dividends?
Vivani Medical, Inc. does not currently pay dividends.
What is Vivani Medical, Inc.’s EPS estimate?
Vivani Medical, Inc.’s EPS estimate is -0.09.
How many shares outstanding does Vivani Medical, Inc. have?
Vivani Medical, Inc. has 59,243,904 shares outstanding.
What happened to Vivani Medical, Inc.’s price movement after its last earnings report?
Vivani Medical, Inc. reported an EPS of -€0.103 in its last earnings report, missing expectations of -€0.086. Following the earnings report the stock price went down -1.005%.
Which hedge fund is a major shareholder of Vivani Medical, Inc.?
Currently, no hedge funds are holding shares in DE:U5P
Vivani Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€3.44 (196.27% Upside)
€3.44 (196.27% Upside)
Insider Transactions
Bought Shares
Worth $4.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.60%
12-Months-Change
Fundamentals
Return on Equity
-177.75%
Trailing 12-Months
Asset Growth
-40.06%
Trailing 12-Months
Company Description
Vivani Medical, Inc.
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
U5P Stock 12 Month Forecast
Average Price Target
€3.44
▲(196.27% Upside)
Technical Analysis
Options Prices
Currently, No data available
---